Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H20N4O6 |
Molecular Weight | 376.3639 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=N2
InChI
InChIKey=AUNGANRZJHBGPY-SCRDCRAPSA-N
InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1
Molecular Formula | C17H20N4O6 |
Molecular Weight | 376.3639 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:49 UTC 2023
by
admin
on
Fri Dec 15 15:06:49 UTC 2023
|
Record UNII |
TLM2976OFR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA11HA04
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LIVERTOX |
NBK548710
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
WHO-ATC |
A11HA04
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
JECFA EVALUATION |
INS-101(III)
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LOINC |
6695-1
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
DSLD |
2543 (Number of products:6659)
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LOINC |
27099-1
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
27
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LOINC |
49038-3
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
NCI_THESAURUS |
C45812
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
FDA ORPHAN DRUG |
352511
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
FDA ORPHAN DRUG |
344911
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LOINC |
18374-9
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LOINC |
2924-9
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
DSLD |
203 (Number of products:536)
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-101(I)
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
FDA ORPHAN DRUG |
468414
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
WHO-ATC |
S01XA26
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
CFR |
21 CFR 184.1695
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-101(III)
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
||
|
LOINC |
73723-9
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
817
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
493570
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
17015
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
INS-101(I)
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
RIBOFLAVIN
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | Description: A yellow to orange-yellow, crystalline powder; odourless or almost odourless. Solubility: Very slightly soluble in water; practically insoluble in ethanol (~750 g/l) TS, ether R, and acetone R. Category: Vitamin. Storage: Riboflavin should be kept in a tightly closed container, protected from light. Additional information: Riboflavin has a bitter taste. Solutions of Riboflavin, especially in dilute solutions of alkalis, deterioraterapidly when exposed to light. Definition: Riboflavin contains not less than 98.0% and not more than 102.0% of C17H20N4O6, calculated with reference to the dried substance. | ||
|
100000089010
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
DTXSID8021777
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
33298
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
176838
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
TLM2976OFR
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
C808
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
1603006
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
Riboflavin
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
201-507-1
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
D012256
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL1534
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
SUB10298MIG
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
419
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
RIBOFLAVIN
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
TLM2976OFR
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
m9595
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | Merck Index | ||
|
2834
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
83-88-5
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
57986
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | |||
|
9346
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB00140
Created by
admin on Fri Dec 15 15:06:49 UTC 2023 , Edited by admin on Fri Dec 15 15:06:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
correction factors: for the calculation of content, multiply the peak areas of the following impurity by the corresponding correction factor: impurity C = 2.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
correction factors: for the calculation of content, multiply the peak areas of the following impurity by the corresponding correction factor: impurity B = 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
correction factors: for the calculation of content, multiply the peak areas of the following impurity by the corresponding correction factor: impurity A = 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
|
||
|
IMPURITY -> PARENT |
correction factors: for the calculation of content, multiply the peak areas of the following impurity by the corresponding correction factor: impurity D = 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
Ph.Eur.; USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|